SUMO-Modification of Human Nrf2 at K110 and K533 Regulates Its Nucleocytoplasmic Localization, Stability and Transcriptional Activity

• Treniqka S. Walters,
• Deneshia J. McIntosh,
• Shalonda M. Ingram,
• Lakeisha Tillery,
• Evangeline D. Motley,
• Ifeanyi J. Arinze,
• Smita Misra

Affiliations

Treniqka S. Walters

Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN, USA

Deneshia J. McIntosh

Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN, USA

Shalonda M. Ingram

Department of Microbiology, Immunology and Physiology, School of Medicine, Meharry Medical College, Nashville, TN, USA

Lakeisha Tillery

Department of Microbiology, Immunology and Physiology, School of Medicine, Meharry Medical College, Nashville, TN, USA

Evangeline D. Motley

Department of Microbiology, Immunology and Physiology, School of Medicine, Meharry Medical College, Nashville, TN, USA

Ifeanyi J. Arinze

Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN, USA

Smita Misra

Department of Microbiology, Immunology and Physiology, School of Medicine, Meharry Medical College, Nashville, TN, USA; School of Graduate Studies and Research, Meharry Medical College, Nashville TN, USA; Center for Women’s Health, Meharry Medical College, Nashville TN, USA